26th Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology

November 17-18, 2016
HorutoHall OITA , Oita, Japan

FIRST AUTHOR INDEX
First Name	Last Name	No.	Title
Hitoshi	Sakurai	PJ-1	Increasing Versus Maintaining the Dose of Olanzapine or Risperidone for Schizophrenia Patients Who Did Not Respond to Modest Dosage:A Double-Blind Randomized Controlled Trial
Yoshiteru	Takekita	EN-3	Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial